<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101092707</journal-id>
<journal-id journal-id-type="pubmed-jr-id">22472</journal-id>
<journal-id journal-id-type="nlm-ta">Proteomics</journal-id>
<journal-id journal-id-type="iso-abbrev">Proteomics</journal-id>
<journal-title-group>
<journal-title>Proteomics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1615-9853</issn>
<issn pub-type="epub">1615-9861</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28508553</article-id>
<article-id pub-id-type="pmc">5863538</article-id>
<article-id pub-id-type="doi">10.1002/pmic.201600232</article-id>
<article-id pub-id-type="manuscript">NIHMS888164</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A targeted proteomic assay for the measurement of plasma proteoforms related to human aging phenotypes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Semba</surname>
<given-names>Richard D.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN2">*</xref>
<xref ref-type="author-notes" rid="FN1">#</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Pingbo</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN2">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Min</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fabbri</surname>
<given-names>Elisa</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gonzalez-Freire</surname>
<given-names>Marta</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moaddel</surname>
<given-names>Ruin</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Geng-Spyropoulos</surname>
<given-names>Minghui</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ferrucci</surname>
<given-names>Luigi</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD</aff>
<aff id="A2">
<label>2</label>National Institute on Aging, National Institutes of Health, Baltimore, MD</aff>
<author-notes>
<corresp id="FN1"><label>#</label>Correspondence: Dr. Richard Semba, Smith Building M015, 400 N. Broadway, Baltimore, MD 21287. Tel. (410) 955-3572. <email>rdsemba@jhmi.edu</email></corresp>
<fn fn-type="equal" id="FN2">
<label>*</label>
<p id="P1">These authors contributed equally to the manuscript.</p>
</fn>
<fn fn-type="COI-statement" id="FN3">
<p id="P31">The authors declare no conflicts of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>6</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>8</month>
<year>2018</year>
</pub-date>
<volume>17</volume>
<issue>15-16</issue>
<elocation-id>10.1002/pmic.201600232</elocation-id>
<abstract>
<p id="P2">Circulating polypeptides and proteins have been implicated in reversing or accelerating aging phenotypes, including growth/differentiation factor 8 (GDF8), GDF11, eotaxin, and oxytocin. These proteoforms, which are defined as the protein products arising from a single gene due to alternative splicing and post-translational modifications, have been challenging to study. Both GDF8 and GDF11 have known antagonists such as follistatin (FST), and WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing proteins 1 and 2 (WFIKKN1, WFIKKN2). We developed a novel multiplexed selected reaction monitoring (SRM) assay using liquid chromatography-tandem mass spectrometry to measure five proteins related to GDF8 and GDF11 signaling, and in addition, eotaxin and oxytocin. Eighteen peptides consisting of 54 transitions were monitored and validated in pooled human plasma. In twenty-four adults, the mean (SD) concentrations (ng/mL) were as follows: GDF8 propeptide, 11.0 (2.4); GDF8 mature protein, 25.7 (8.0); GDF11 propeptide, 21.3 (10.9); GDF11 mature protein, 16.5 (12.4); FST, 29.8 (7.1); FST cleavage form FST303, 96.4 (69.2); WFIKKN1, 38.3 (8.3); WFIKKN2, 32.2 (10.5); oxytocin, 1.9 (0.9); and eotaxin, 2.3 (0.5). This novel multiplexed SRM assay should facilitate the study of the relationships of these proteoforms with major aging phenotypes.</p>
</abstract>
<kwd-group>
<kwd>aging</kwd>
<kwd>eotaxin</kwd>
<kwd>follistatin</kwd>
<kwd>growth/differentiation factor 8</kwd>
<kwd>growth/differentiation factor 11</kwd>
<kwd>oxytocin</kwd>
<kwd>WFIKKN1</kwd>
<kwd>WFIKKN2</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>